Staphylococcus pseudintermedius's PBP4 Is Directly Associated with the Dissociated Oxacillin and Cefoxitin Phenotype

Paula Gagetti1, Roberto R Rosato2, Adriana E Rosato3,4

  • 1Servicio Antimicrobianos, INEI-ANLIS, Buenos Aires 1281, Argentina.

Insights

Methicillin-resistant Staphylococcus pseudintermedius (MRSP) poses treatment challenges. This study reveals that PBP4

Area of Science:

  • Veterinary Microbiology
  • Antimicrobial Resistance
  • Molecular Biology

Background:

  • Staphylococcus pseudintermedius is a significant pathogen in veterinary and human medicine.
  • The rise of multidrug-resistant strains, including methicillin-resistant S. pseudintermedius (MRSP), complicates treatment.
  • Current laboratory methods using cefoxitin disks are insufficient for detecting MRSP's beta-lactam resistance.

Purpose of the Study:

  • To investigate the molecular mechanisms behind the differing resistance patterns to oxacillin and cefoxitin in MRSP.
  • To understand why cefoxitin disk tests fail to accurately detect methicillin resistance in S. pseudintermedius.

Main Methods:

  • Analysis of Penicillin-Binding Proteins (PBP) profiles in MRSP.
  • Assessment of PBP affinity for various beta-lactam antibiotics.
  • Sequencing of PBP genes to identify resistance-associated mutations.

Main Results:

  • Penicillin-Binding Protein 4 (PBP4) retains affinity for cefoxitin in MRSP.
  • This retained affinity of PBP4 for cefoxitin interferes with the accurate phenotypic detection of resistance.
  • The study identified PBP4 as the key factor in the dissociated oxacillin and cefoxitin resistance phenotype.

Conclusions:

  • Staphylococcus pseudintermedius PBP4 is directly implicated in the discordant oxacillin and cefoxitin resistance.
  • Understanding this mechanism is crucial for accurate diagnosis and effective treatment of MRSP infections.
  • This finding highlights the need for revised diagnostic strategies for MRSP in clinical microbiology.